Article metrics
PDF
Other content recommended for you
- Access to investigational medicinal products for minors in Europe: ethical and regulatory issues in negotiating children's access to investigational medicines
- Achieving equal and timely access to innovative anticancer drugs in the European Union (EU): summary of a multidisciplinary CECOG-driven roundtable discussion with a focus on Eastern and South-Eastern EU countries
- Expanded access: growing importance to public health
- Trump signs bill to give patients right to try drugs
- Emerging immunotherapies in multiple myeloma
- Plasma cell leukaemia with t(11;14) not responsive to venetoclax
- Shortage of essential antimicrobials: a major challenge to global health security
- First report of CART treatment in AL amyloidosis and relapsed/refractory multiple myeloma
- Accessing unproven interventions in the COVID-19 pandemic: discussion on the ethics of ‘compassionate therapies’ in times of catastrophic pandemics
- Efficacy and safety of avelumab treatment in patients with metastatic Merkel cell carcinoma: experience from a global expanded access program